BACKGROUND: At present, the expression of MOR1 and its function in gastric cancer remains unclear with evidence suggesting that it is to be involved in tumor progression and metastasis. The study was to assess the clinicopathologic relevance and prognostic value of MOR1 expression in gastric cancer. METHODS: Real-time quantitative RT-PCR and immunohistochemical staining were used to detect MOR1 expression in primary gastric cancerous surgical specimens and adjacent nontumorous tissues. RESULTS: High MOR1 expression was detected in cancerous tumor compared with their adjacent nontumorous tissues. In addition, the chi-square test revealed that high MOR1 expression was significantly correlated with depth of invasion (p = 0.006), lymph node metastasis (p = 0.001), distant metastasis (p = 0.017), and TNM staging (p = 0.027). Moreover, Kaplan-Meier analysis revealed a significant association between MOR1 expression and overall survival. High expression of MOR1 was identified as an independent and significant predictor gene of reduced postoperative survival. CONCLUSION: We conclude that MOR1 expression may be a useful biomarker for better prediction of the clinical outcome and management of gastric cancer patients.
BACKGROUND: At present, the expression of MOR1 and its function in gastric cancer remains unclear with evidence suggesting that it is to be involved in tumor progression and metastasis. The study was to assess the clinicopathologic relevance and prognostic value of MOR1 expression in gastric cancer. METHODS: Real-time quantitative RT-PCR and immunohistochemical staining were used to detect MOR1 expression in primary gastric cancerous surgical specimens and adjacent nontumorous tissues. RESULTS: High MOR1 expression was detected in cancerous tumor compared with their adjacent nontumorous tissues. In addition, the chi-square test revealed that high MOR1 expression was significantly correlated with depth of invasion (p = 0.006), lymph node metastasis (p = 0.001), distant metastasis (p = 0.017), and TNM staging (p = 0.027). Moreover, Kaplan-Meier analysis revealed a significant association between MOR1 expression and overall survival. High expression of MOR1 was identified as an independent and significant predictor gene of reduced postoperative survival. CONCLUSION: We conclude that MOR1 expression may be a useful biomarker for better prediction of the clinical outcome and management of gastric cancerpatients.
Authors: Marie Fallon; Carlo Reale; Andrew Davies; A Eberhard Lux; Kirushna Kumar; Andrzej Stachowiak; Rafael Galvez Journal: J Support Oncol Date: 2011 Nov-Dec
Authors: Patrick A Singleton; Nurbek Mambetsariev; Frances E Lennon; Biji Mathew; Jessica H Siegler; Liliana Moreno-Vinasco; Ravi Salgia; Jonathan Moss; Joe Gn Garcia Journal: J Angiogenes Res Date: 2010-02-19
Authors: Kalpna Gupta; Smita Kshirsagar; Liming Chang; Robert Schwartz; Ping-Y Law; Doug Yee; Robert P Hebbel Journal: Cancer Res Date: 2002-08-01 Impact factor: 12.701
Authors: Diane M Novy; David V Nelson; Dhanalakshmi Koyyalagunta; Juan P Cata; Pankaj Gupta; Kalpna Gupta Journal: Pain Date: 2020-03 Impact factor: 6.961
Authors: Bruce H Chamberlain; Michelle Rhiner; Neal E Slatkin; Nancy Stambler; Robert J Israel Journal: J Pain Res Date: 2021-09-01 Impact factor: 3.133
Authors: Amparo Belltall; Guido Mazzinari; Iris Garrido-Cano; Francisco Giner; Anabel Marqués Marí; Pilar Eroles; María Pilar Argente-Navarro; Juan Pablo Cata; Oscar Diaz-Cambronero Journal: Front Oncol Date: 2022-04-06 Impact factor: 5.738
Authors: Darren M Brenner; Neal E Slatkin; Nancy Stambler; Robert J Israel; Paul H Coluzzi Journal: Support Care Cancer Date: 2021-02-25 Impact factor: 3.603